Collectively, our findings indicate that UBE2D1-driven CD14<sup>+</sup>CXCL10<sup>+</sup> monocytes are central to sJIA pathogenesis and may represent both a biomarker and a therapeutic target for disease monitoring and intervention. The gene discussed is UBE2D1; the disease is systemic-onset juvenile idiopathic arthritis.